Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01597388
First received: March 28, 2012
Last updated: October 18, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)